Long‐term efficacy of danazol treatment in hereditary angioedema

Eur J Clin Invest 2011; 41 (3): 256–262

[1]  M. Frank,et al.  Danazol in the Treatment of Hereditary Angioedema , 1980, Drugs.

[2]  D. Johnston.  Diagnosis and Management of Hereditary Angioedema , 2011, The Journal of the American Osteopathic Association.

[3]  T. Klingebiel,et al.  C1‐inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis , 2009, Transfusion.

[4]  J. Kastelein,et al.  Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema. , 2008, Clinical therapeutics.

[5]  A. Goren,et al.  Hereditary angioedema: new hopes for an orphan disease. , 2008, The Israel Medical Association journal : IMAJ.

[6]  H. Farkas,et al.  Long-term danazol prophylaxis does not lead to increased carotid intima-media thickness in hereditary angioedema patients. , 2008, Atherosclerosis.

[7]  K. Bork,et al.  Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[8]  M. Frank.  8. Hereditary angioedema. , 2008, The Journal of allergy and clinical immunology.

[9]  M. Frank.  Hereditary angiodema: a current state-of-the-art review, VI: novel therapies for hereditary angioedema. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[10]  William H. Yang,et al.  Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[11]  B. Zuraw.  Hereditary angiodema: a current state-of-the-art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new? , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[12]  A. Sheffer,et al.  Hereditary angioedema: a current state-of-the-art review, V: attenuated androgens for the treatment of hereditary angioedema. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[13]  J. Schölmerich,et al.  Lack of dehydroepiandrosterone in type I and II hereditary angioedema and role of danazol in steroid hormone conversion , 2007, Allergy.

[14]  M. Cicardi,et al.  The deficiency of C1 inhibitor and its treatment. , 2007, Immunobiology.

[15]  M. Frank.  Hereditary angioedema: the clinical syndrome and its management in the United States. , 2006, Immunology and allergy clinics of North America.

[16]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[17]  L. Romics,et al.  Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. , 2005, The Journal of allergy and clinical immunology.

[18]  K. Kragballe,et al.  Hereditary Angioedema. , 2018, The New England journal of medicine.

[19]  M. Cicardi,et al.  Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol. , 2003, Immunology letters.

[20]  G. Ceballos-Reyes,et al.  Testosterone inhibits bradykinin-induced intracellular calcium kinetics in rat aortic endothelial cells in culture , 2002, Steroids.

[21]  W. Tremaine,et al.  Hereditary angioedema: a broad review for clinicians. , 2001, Archives of internal medicine.

[22]  H. Teoh,et al.  ACUTE EXPOSURE TO A LOW LEVEL OF TESTOSTERONE IMPAIRS RELAXATION IN PORCINE CORONARY ARTERIES , 1999, Clinical and experimental pharmacology & physiology.

[23]  A. Davis,et al.  Regulation of C1 inhibitor synthesis. , 1998, Immunobiology.

[24]  M. Cicardi,et al.  Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. , 1997, The Journal of allergy and clinical immunology.

[25]  D. Bouscary,et al.  Danazol-induced hepatocellular adenoma. , 1990, The American journal of medicine.

[26]  A. Falus,et al.  Hormonal regulation of complement biosynthesis in human cell lines--II. Upregulation of the biosynthesis of complement components C3, factor B and C1 inhibitor by interleukin-6 and interleukin-1 in human hepatoma cell line. , 1990, Molecular immunology.

[27]  A. Agostoni,et al.  Inherited C1 inhibitor deficiency. , 1989, Complement and inflammation.

[28]  A. Sheffer,et al.  Clinical and biochemical effects of stanozolol therapy for hereditary angioedema. , 1981, The Journal of allergy and clinical immunology.

[29]  E. Brown,et al.  Long-term therapy of hereditary angioedema with danazol. , 1980, Annals of internal medicine.

[30]  M. Cicardi,et al.  Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema. , 1980, The Journal of allergy and clinical immunology.

[31]  A. Sheffer,et al.  Clinical and biochemical effects of impeded androgen (oxymetholone) therapy of hereditary angioedema. , 1979, The Journal of allergy and clinical immunology.

[32]  J. Atkinson.  Diagnosis and management of hereditary angioedema (HAE). , 1979, Annals of allergy.

[33]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.

[34]  J. Atkinson,et al.  Hereditary angioedema: the clinical syndrome and its management. , 1976, Annals of internal medicine.

[35]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.